Compass Pathways’ Leads the Way as the First Psychedelics Company To IPO on the Nasdaq

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – September 24, 2020 – Last year may have been all about cannabis, but it’s clear that 2020 and beyond belongs to the psychedelic medicine market. Ever since Johnson & Johnson’s (NYSE:JNJ) ketamine-derived medicine, Spravato, received the first nod of approval from the US […]